BioCentury
ARTICLE | Financial News

Alexion slips as Street digests whistleblower allegations

November 12, 2016 12:14 AM UTC

Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) slid $13.26 (10%) to $113.62 on Friday, reflecting continued investor concerns after the company on Wednesday said it was delaying its 3Q16 10-Q filing while it investigates a former employee’s allegations that company personnel engaged in sales practices "inconsistent" with Alexion's policies...

BCIQ Company Profiles

Alexion Pharmaceuticals Inc.